Decision was prompted by news of tax break on profits from U.K.-owned IP.
The firm expects projects to range from process/product development to clinical development, fill/finish operations, and commercial product manufacturing.
Firms will produce custom synthetic double-stranded nucleic acids up to 5 kb.
Contract development and manufacturing services firm offers preclinical development through to commercial manufacturing of parenteral, solid, semisolid, and liquid dosage forms.
Torque, a developer of T-cell cancer therapeutics produced through its Deep-Priming™ technology platform, says its Slipstream™ process for making Deep-Primed T-Cells is designed to deliver substantially greater efficiency over current cell therapy manufacturing through savings in cost, time, and labor.
Aldevron was selected to produce CureLab Oncology’s DNA-based vaccine for cancer treatment.
TEDCO and DoD Grants will fund Biodefense mAb R&D and manufacturing platform for virus-like replicon particle vaccines.